plasma cell lifespan quantitative systems pharmacology qsp matlab r2023b simbiology (MathWorks Inc)
MathWorks Inc is a verified supplier 
97
Structured Review
MathWorks Inc
plasma cell lifespan quantitative systems pharmacology qsp matlab r2023b simbiology
Plasma Cell Lifespan Quantitative Systems Pharmacology Qsp Matlab R2023b Simbiology, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 97/100, based on 595 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/matlab+simbiology/SimBiology/pm41935544-102-88-95
Average 97 stars, based on 595 article reviews
Plasma Cell Lifespan Quantitative Systems Pharmacology Qsp Matlab R2023b Simbiology, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 97/100, based on 595 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/matlab+simbiology/SimBiology/pm41935544-102-88-95
Average 97 stars, based on 595 article reviews
plasma cell lifespan quantitative systems pharmacology qsp matlab r2023b simbiology - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
other:Article Title: Efficient dimensional and computational reduction of lactate dehydrogenase (LDH) system by integrating QSSA, CSP, fast-slow dynamics and visualization: A framework using MATLAB SimBiology and Simulink. Article Snippet: This study investigates the application of analytical and computational techniques to simplify enzyme-catalyzed multi-substrate reaction systems, emphasizing dimensional reduction strategies for complex kinetic models.. By integrating the Michaelis-Menten framework with methodologies such as Quasi-Steady-State Approximation (QSSA), Computational Singular Perturbation (CSP), and sensitivity analysis, we validate low-dimensional approximations that capture the temporal dynamics of fast and slow species in enzymatic interactions.. A key innovation is the separate evaluation of the Slow Invariant Manifold (SIM) for reduced species, diverging from conventional approaches that analyze all species collectively. Article Title: Prediction of the Quantitative Biodistribution of Inhaled Titanium Dioxide Nanoparticles Using the Physiologically Based Toxicokinetic Modelling Method Article Snippet: All equations were solved in Article Title: B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab‐Mediated B Cell Depletion in Rheumatic Diseases Article Snippet: The model was developed using Article Title: B Cell Differentiation Model for Identifying Predictors of Responses to Rituximab-Mediated B Cell Depletion in Rheumatic Diseases. Article Snippet: The model was developed using Article Title: Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [ 177 Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC Model Article Snippet: The PBPK model, implemented in Article Title: Evaluation of RBC Targeting As a Strategy to Extend Half-Life and Reduce Nonspecific Tissue Uptake of Biologics. Article Snippet: Delivery strategies exploiting red blood cells (RBCs) have been widely pursued, particularly for the purpose of achieving sustained systemic exposure to small molecule drugs.. However, limited efforts have been focused on applying RBCinspired delivery strategies to biologic therapies.. We aimed to evaluate RBC binding as a potential strategy to achieve systemic half-life extension or reduced tissue accessibility of antibodies, including those having intravascular targets or safety liabilities within peripheral tissues. Article Title: Prediction of the Quantitative Biodistribution of Inhaled Titanium Dioxide Nanoparticles Using the Physiologically Based Toxicokinetic Modelling Method. Article Snippet: All equations were solved in Drug discovery:Article Title: Evolutionary digital twin framework for optimal aminoglycoside dosing in neonates with suspected sepsis. Article Snippet: .. Recapitulation of observed amikacin pharmacokinetics The fully calibrated PBPK–PD model was implemented in |
